Filing Details

Accession Number:
0001104659-21-072621
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-26 21:32:21
Reporting Period:
2021-05-24
Accepted Time:
2021-05-26 21:32:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1472012 Immunome Inc. IMNM Pharmaceutical Preparations (2834) 770694340
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1826906 Michael Lefenfeld C/O Immunome, Inc.
665 Stockton Drive, Suite 300
Exton PA 19341
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-24 600 $17.80 22,822 No 4 P Direct
Common Stock Acquisiton 2021-05-25 2,715 $18.44 25,537 No 4 P Direct
Common Stock Acquisiton 2021-05-26 1,335 $19.03 26,872 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $18.38 to $18.52, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
  2. The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $18.66 to $19.43, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.